Successful intravenous thrombolysis in acute ischemic stroke after reversal of dabigatran etexilate with idarucizumab at the end of therapeutic time window

Successful intravenous thrombolysis in acute ischemic stroke after reversal of dabigatran etexilate with idarucizumab at the end of therapeutic time window

Dabigatran is a direct oral anticoagulant that is widely used for stroke prevention in patients with atrial fibrillation. We report a case of an 80-year-old stroke patient on dabigatran for permanent atrial fibrillation, who presented with an initial National Institutes of Health Stroke Scale (NIHSS...

Full description

Bibliographic Details
Main Authors: Gorana Vukorepa, Sabina Deveđija*, Miljenko Crnjaković, Mirna Karakaš, Zeljka Cuk
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Turkish Journal of Emergency Medicine
Subjects:
acute ischemic stroke
acute stroke therapy
anticoagulants
dabigatran
idarucizumab
thrombolysis
Online Access:http://www.turkjemergmed.org/article.asp?issn=2452-2473;year=2020;volume=20;issue=2;spage=90;epage=92;aulast=Vukorepa

Internet

http://www.turkjemergmed.org/article.asp?issn=2452-2473;year=2020;volume=20;issue=2;spage=90;epage=92;aulast=Vukorepa

Similar Items